Cargando…
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734912/ https://www.ncbi.nlm.nih.gov/pubmed/33317581 http://dx.doi.org/10.1186/s13063-020-04947-2 |
| _version_ | 1783622556635365376 |
|---|---|
| author | Devos, Timothy Geukens, Tatjana Schauwvlieghe, Alexander Ariën, Kevin K. Barbezange, Cyril Cleeren, Myriam Compernolle, Veerle Dauby, Nicolas Desmecht, Daniël Grimaldi, David Lambrecht, Bart N. Luyten, Anne Maes, Piet Moutschen, Michel Romano, Marta Seyler, Lucie Nevessignsky, Michel Toungouz Vandenberghe, Katleen van Griensven, Johan Verbeke, Geert Vlieghe, Erika Yombi, Jean Cyr Liesenborghs, Laurens Verhamme, Peter Meyfroidt, Geert |
| author_facet | Devos, Timothy Geukens, Tatjana Schauwvlieghe, Alexander Ariën, Kevin K. Barbezange, Cyril Cleeren, Myriam Compernolle, Veerle Dauby, Nicolas Desmecht, Daniël Grimaldi, David Lambrecht, Bart N. Luyten, Anne Maes, Piet Moutschen, Michel Romano, Marta Seyler, Lucie Nevessignsky, Michel Toungouz Vandenberghe, Katleen van Griensven, Johan Verbeke, Geert Vlieghe, Erika Yombi, Jean Cyr Liesenborghs, Laurens Verhamme, Peter Meyfroidt, Geert |
| author_sort | Devos, Timothy |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7734912 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77349122020-12-14 Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial Devos, Timothy Geukens, Tatjana Schauwvlieghe, Alexander Ariën, Kevin K. Barbezange, Cyril Cleeren, Myriam Compernolle, Veerle Dauby, Nicolas Desmecht, Daniël Grimaldi, David Lambrecht, Bart N. Luyten, Anne Maes, Piet Moutschen, Michel Romano, Marta Seyler, Lucie Nevessignsky, Michel Toungouz Vandenberghe, Katleen van Griensven, Johan Verbeke, Geert Vlieghe, Erika Yombi, Jean Cyr Liesenborghs, Laurens Verhamme, Peter Meyfroidt, Geert Trials Correction BioMed Central 2020-12-14 /pmc/articles/PMC7734912/ /pubmed/33317581 http://dx.doi.org/10.1186/s13063-020-04947-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Devos, Timothy Geukens, Tatjana Schauwvlieghe, Alexander Ariën, Kevin K. Barbezange, Cyril Cleeren, Myriam Compernolle, Veerle Dauby, Nicolas Desmecht, Daniël Grimaldi, David Lambrecht, Bart N. Luyten, Anne Maes, Piet Moutschen, Michel Romano, Marta Seyler, Lucie Nevessignsky, Michel Toungouz Vandenberghe, Katleen van Griensven, Johan Verbeke, Geert Vlieghe, Erika Yombi, Jean Cyr Liesenborghs, Laurens Verhamme, Peter Meyfroidt, Geert Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial |
| title | Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial |
| title_full | Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial |
| title_fullStr | Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial |
| title_full_unstemmed | Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial |
| title_short | Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial |
| title_sort | correction to: a randomized, multicentre, open-label phase ii proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with covid-19: the donated antibodies working against ncov (dawn-plasma) trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734912/ https://www.ncbi.nlm.nih.gov/pubmed/33317581 http://dx.doi.org/10.1186/s13063-020-04947-2 |
| work_keys_str_mv | AT devostimothy correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT geukenstatjana correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT schauwvlieghealexander correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT arienkevink correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT barbezangecyril correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT cleerenmyriam correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT compernolleveerle correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT daubynicolas correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT desmechtdaniel correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT grimaldidavid correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT lambrechtbartn correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT luytenanne correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT maespiet correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT moutschenmichel correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT romanomarta correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT seylerlucie correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT nevessignskymicheltoungouz correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT vandenberghekatleen correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT vangriensvenjohan correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT verbekegeert correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT vliegheerika correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT yombijeancyr correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT liesenborghslaurens correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT verhammepeter correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial AT meyfroidtgeert correctiontoarandomizedmulticentreopenlabelphaseiiproofofconcepttrialinvestigatingtheclinicalefficacyandsafetyoftheadditionofconvalescentplasmatothestandardofcareinpatientshospitalizedwithcovid19thedonatedantibodiesworkingagainstncovdawnplasmatrial |